Transferrin Saturation, Serum Iron, and Ferritin in Heart Failure: Prognostic Significance and Proteomic Associations
Authors:
- 1 February 2025
- journal article
- Published by Wolters Kluwer Health in Circulation: Heart Failure
- Vol. 18 (2) , e011728
Abstract
BACKGROUND: Iron deficiency (ID) is currently defined as a serum ferritin level P =0.001; serum iron: standardized hazard ratio, 0.87 [95% CI, 0.79–0.96]; P =0.007). Similarly, TSAT was associated with the risk of death or HF-related admission (standardized hazard ratio, 0.89 [95% CI, 0.83–0.95]; P =0.0006). Significant interactions between TSAT and HF with preserved ejection fraction status were found such that TSAT was more strongly associated with the risk of death and death or HF-related admission in HF with preserved ejection fraction. We identified 359 proteins associated with TSAT, including TFRC (transferrin receptor protein; β, −0.455; P P <0.0001). Pathway analyses demonstrated associations with lipid metabolism, complement activation, and inflammation. In contrast to the robust associations between TSAT and outcomes, ID and absolute ID defined by current criteria were not associated with death or death or HF-related admission. TSAT was associated with outcomes regardless of the presence of functional versus absolute ID. CONCLUSIONS: Low TSAT, but not ferritin concentrations, is significantly associated with adverse outcomes in HF. Low TSAT is more strongly associated with outcomes in HF with preserved ejection fraction. Pathways related to inflammation and lipid metabolism are associated with low TSAT in HF.Keywords
This publication has 44 references indexed in Scilit:
- Iron deficiency and biomarkers of inflammation: a 3-year prospective analysis of the DO-HEALTH trialAging Clinical and Experimental Research, 2021
- High soluble transferrin receptor in patients with heart failure: a measure of iron deficiency and a strong predictor of mortalityEuropean Journal of Heart Failure, 2020
- 2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart FailureJACC, 2017
- Iron deficiency across chronic inflammatory conditions: International expert opinion on definition, diagnosis, and managementAmerican Journal of Hematology, 2017
- Novel Pathomechanisms of Cardiomyocyte Dysfunction in a Model of Heart Failure with Preserved Ejection FractionEuropean Journal of Heart Failure, 2016
- Iron deficiency in chronic heart failure: An international pooled analysisAmerican Heart Journal, 2013
- Iron Deficiency Predicts Impaired Exercise Capacity in Patients With Systolic Chronic Heart FailureJournal of Cardiac Failure, 2011
- Serum transferrin receptorAmerican Journal of Hematology, 2008
- A multiple testing correction method for genetic association studies using correlated single nucleotide polymorphismsGenetic Epidemiology, 2008
- Usefulness of C-reactive protein as an independent predictor of death in patients with ischemic cardiomyopathyThe American Journal of Cardiology, 2005